NIH-funded research Sbir 2 grant

Wearable respiratory monitor to prevent opioid-related breathing problems

Official title: Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression

Funded at Rtm Vital Signs, LLC · NIH-11237086 · Data updated 2026-11-12

A wearable, wireless sensor system with a smart algorithm that detects and predicts opioid-induced breathing depression to help hospital patients and others stay safe.

More Depression research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionRtm Vital Signs, LLC
NIH-funded
Lab location1 site (Philadelphia, UNITED STATES)
Project startSeptember 15, 2023
Project endNovember 30, 2026
Funding year2026
Award (this year)$1,252,788
NIH project number5R44DA059491-03
Project IDNIH-11237086 on NIH RePORTER

Who could benefit from this research

Could help

Hospitals’ general-floor patients receiving opioids and individuals at risk of opioid-related breathing problems, including those with chronic opioid use.

Less likely to help

Patients without opioid exposure or those not needing respiratory monitoring may not benefit.

What this research studies

This project aims to create a wearable device that continuously tracks breathing, oxygen levels, heart rate, movement, and more to spot early signs of opioid-related breathing problems. It uses a unique acoustic sensor and software to compute a Risk Index Score every 20 seconds, so clinicians can act before severe events occur. The goal is to reduce hospital stays, complications, and deaths due to OIRD by providing timely alerts to care teams. The device is designed for use on general hospital floors and for people who chronically use or misuse opioids. The team has FDA breakthrough designation, signaling potential real-world impact if successful.

Why it matters

Potential benefit: If successful, patients on opioid therapy could receive timely alerts that prevent life-threatening breathing problems.

How similar studies have gone: Previous monitoring tools have struggled to reliably predict OIRD, making this approach potentially novel and impactful.

Where this research is happening

  • Rtm Vital Signs, LLC
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Dicciani, Nance Katherine — Rtm Vital Signs, LLC
  • Study coordinator: Dicciani, Nance Katherine

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.